Hematology/Oncology

Top Story

Memorial Sloan Kettering Cancer Center names head of solid tumor oncology

Memorial Sloan Kettering Cancer Center names head of solid tumor oncology
April 26, 2017

Luis A. Diaz, MD, has been named head of the division of solid tumor oncology in the department of medicine at Memorial Sloan Kettering Cancer Center.

Diaz — whose interests include cancer genetics and immuno-oncology — will continue his clinical practice with the center’s gastrointestinal oncology service. He specializes in the treatment of colorectal and pancreatic cancers.

Meeting News

Vaccine-type HPV prevalence in US declines 65% among young women

April 26, 2017
Since the HPV vaccine was first introduced in the United States in 2006, researchers observed a 65% decline in the overall prevalence of vaccine-type HPV among women…
Meeting NewsPerspective

Flu vaccine may cause immune-related adverse events with checkpoint inhibitors

April 26, 2017
Patients treated with PD-1/PD-L1 checkpoint inhibitors may be at an increased risk for adverse events after receiving the seasonal influenza vaccination, according to…
In the Journals

High-quality diet linked to lower CRC risk across racial, ethnic groups

April 26, 2017
Researchers associated high-quality dietary patterns defined by four different diet quality indexes with a reduced risk for colorectal cancer across a number of racial…
In the Journals Plus

Intratumor heterogeneity increases risk for NSCLC recurrence, death

April 26, 2017
Intratumor heterogeneity mediated through chromosome instability increased risk for recurrence or death in patients with
More News Headlines »
CME

Immune Checkpoint Inhibitors for Advanced Bladder Cancer: Applying Clinical Advances and Elucidating Best Practices

This activity is supported by an educational grant from Merck & Co, Inc.

Advances in immunology and the advent of immune checkpoint blockade inhibition for advanced bladder cancer are poised…
More »
Video
Meeting News

VIDEO: Cappelli discusses autoimmune complications from cancer therapy

April 8, 2017
More »
Featured
American Association for Cancer Research Annual Meeting

American Association for Cancer Research Annual Meeting

CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement